219 related articles for article (PubMed ID: 19368416)
1. The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism.
Malone RP; Waheed A
Drugs; 2009; 69(5):535-48. PubMed ID: 19368416
[TBL] [Abstract][Full Text] [Related]
2. Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders.
Malone RP; Gratz SS; Delaney MA; Hyman SB
CNS Drugs; 2005; 19(11):923-34. PubMed ID: 16268664
[TBL] [Abstract][Full Text] [Related]
3. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
Baghdadli A; Gonnier V; Aussilloux C
Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
[TBL] [Abstract][Full Text] [Related]
4. Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness.
Malone RP; Maislin G; Choudhury MS; Gifford C; Delaney MA
J Am Acad Child Adolesc Psychiatry; 2002 Feb; 41(2):140-7. PubMed ID: 11837403
[TBL] [Abstract][Full Text] [Related]
5. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Loy JH; Merry SN; Hetrick SE; Stasiak K
Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
[TBL] [Abstract][Full Text] [Related]
6. Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder. An open label maintenance study.
Gencer O; Emiroglu FN; Miral S; Baykara B; Baykara A; Dirik E
Eur Child Adolesc Psychiatry; 2008 Jun; 17(4):217-25. PubMed ID: 18026891
[TBL] [Abstract][Full Text] [Related]
7. Use of atypical antipsychotics in the treatment of autistic disorder.
Stachnik JM; Nunn-Thompson C
Ann Pharmacother; 2007 Apr; 41(4):626-34. PubMed ID: 17389666
[TBL] [Abstract][Full Text] [Related]
8. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form].
Desjardins S; Doyen C; Contejean Y; Kaye K; Paubel P
Encephale; 2009 Apr; 35(2):168-72. PubMed ID: 19393386
[TBL] [Abstract][Full Text] [Related]
10. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
[TBL] [Abstract][Full Text] [Related]
11. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
12. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.
McDougle CJ; Scahill L; McCracken JT; Aman MG; Tierney E; Arnold LE; Freeman BJ; Martin A; McGough JJ; Cronin P; Posey DJ; Riddle MA; Ritz L; Swiezy NB; Vitiello B; Volkmar FR; Votolato NA; Walson P
Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):201-24. PubMed ID: 10674197
[TBL] [Abstract][Full Text] [Related]
13. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
Adler BA; Wink LK; Early M; Shaffer R; Minshawi N; McDougle CJ; Erickson CA
Autism; 2015 Jan; 19(1):102-6. PubMed ID: 24571823
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotics in the treatment of autism.
Posey DJ; Stigler KA; Erickson CA; McDougle CJ
J Clin Invest; 2008 Jan; 118(1):6-14. PubMed ID: 18172517
[TBL] [Abstract][Full Text] [Related]
15. Risperidone versus haloperidol in children and adolescents with AD : a randomized, controlled, double-blind trial.
Miral S; Gencer O; Inal-Emiroglu FN; Baykara B; Baykara A; Dirik E
Eur Child Adolesc Psychiatry; 2008 Feb; 17(1):1-8. PubMed ID: 18080171
[TBL] [Abstract][Full Text] [Related]
16. [Risperidone use in child and adolescent psychiatric patients].
Chevreuil C; Reymann JM; Frémaux T; Polard E; Séveno T; Bentué-Ferrer D
Therapie; 2008; 63(5):359-75. PubMed ID: 19154706
[TBL] [Abstract][Full Text] [Related]
17. Role of risperidone in children with autism spectrum disorder.
Chavez B; Chavez-Brown M; Rey JA
Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
[TBL] [Abstract][Full Text] [Related]
18. Second generation antipsychotics in Asperger's Disorder and high functioning autism: a systematic review of the literature and effectiveness of meta-analysis.
Sochocky N; Milin R
Curr Clin Pharmacol; 2013 Nov; 8(4):370-9. PubMed ID: 24050741
[TBL] [Abstract][Full Text] [Related]
19. Risperidone in children with autism and serious behavioral problems.
McCracken JT; McGough J; Shah B; Cronin P; Hong D; Aman MG; Arnold LE; Lindsay R; Nash P; Hollway J; McDougle CJ; Posey D; Swiezy N; Kohn A; Scahill L; Martin A; Koenig K; Volkmar F; Carroll D; Lancor A; Tierney E; Ghuman J; Gonzalez NM; Grados M; Vitiello B; Ritz L; Davies M; Robinson J; McMahon D;
N Engl J Med; 2002 Aug; 347(5):314-21. PubMed ID: 12151468
[TBL] [Abstract][Full Text] [Related]
20. Ziprasidone in adolescents with autism: an open-label pilot study.
Malone RP; Delaney MA; Hyman SB; Cater JR
J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):779-90. PubMed ID: 18315450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
